Report for Getsios D

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (8)

Title : Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US - Saint-Laurent_2015_J.Med.Econ_18_930
Author(s) : Saint-Laurent Thibault C , Ozer Stillman I , Chen S , Getsios D , Proskorovsky I , Hernandez L , Dixit S
Ref : J Med Econ , 18 :930 , 2015
Abstract : Saint-Laurent_2015_J.Med.Econ_18_930
ESTHER : Saint-Laurent_2015_J.Med.Econ_18_930
PubMedSearch : Saint-Laurent_2015_J.Med.Econ_18_930
PubMedID: 26086535

Title : Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation - Hartz_2012_BMC.Neurol_12_2
Author(s) : Hartz S , Getsios D , Tao S , Blume S , Maclaine G
Ref : BMC Neurol , 12 :2 , 2012
Abstract : Hartz_2012_BMC.Neurol_12_2
ESTHER : Hartz_2012_BMC.Neurol_12_2
PubMedSearch : Hartz_2012_BMC.Neurol_12_2
PubMedID: 22316501

Title : NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used? - Getsios_2007_Pharmacoeconomics_25_997
Author(s) : Getsios D , Migliaccio-Walle K , Caro JJ
Ref : Pharmacoeconomics , 25 :997 , 2007
Abstract : Getsios_2007_Pharmacoeconomics_25_997
ESTHER : Getsios_2007_Pharmacoeconomics_25_997
PubMedSearch : Getsios_2007_Pharmacoeconomics_25_997
PubMedID: 18047386

Title : Assessing the health and economic impact of galantamine treatment in patients with Alzheimer's disease in the health care systems of different countries - Caro_2004_Drugs.Aging_21_677
Author(s) : Caro J , Salas M , Ward A , Getsios D , Migliaccio-Walle K , Garfield F
Ref : Drugs & Aging , 21 :677 , 2004
Abstract : Caro_2004_Drugs.Aging_21_677
ESTHER : Caro_2004_Drugs.Aging_21_677
PubMedSearch : Caro_2004_Drugs.Aging_21_677
PubMedID: 15287825

Title : Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysis - Caro_2003_BMC.Geriatr_3_6
Author(s) : Caro J , Getsios D , Migliaccio-Walle K , Ishak J , El-Hadi W
Ref : BMC Geriatr , 3 :6 , 2003
Abstract : Caro_2003_BMC.Geriatr_3_6
ESTHER : Caro_2003_BMC.Geriatr_3_6
PubMedSearch : Caro_2003_BMC.Geriatr_3_6
PubMedID: 14675494

Title : Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK - Ward_2003_Int.J.Geriatr.Psychiatry_18_740
Author(s) : Ward A , Caro JJ , Getsios D , Ishak K , O'Brien J , Bullock R
Ref : Int J Geriatr Psychiatry , 18 :740 , 2003
Abstract : Ward_2003_Int.J.Geriatr.Psychiatry_18_740
ESTHER : Ward_2003_Int.J.Geriatr.Psychiatry_18_740
PubMedSearch : Ward_2003_Int.J.Geriatr.Psychiatry_18_740
PubMedID: 12891643

Title : Assessment of Health Economics in Alzheimer's Disease (AHEAD): Treatment with Galantamine in Sweden - Garfield_2002_Pharmacoeconomics_20_629
Author(s) : Garfield FB , Getsios D , Caro JJ , Wimo A , Winblad B
Ref : Pharmacoeconomics , 20 :629 , 2002
Abstract : Garfield_2002_Pharmacoeconomics_20_629
ESTHER : Garfield_2002_Pharmacoeconomics_20_629
PubMedSearch : Garfield_2002_Pharmacoeconomics_20_629
PubMedID: 12141890

Title : Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands - Caro_2002_Dement.Geriatr.Cogn.Disord_14_84
Author(s) : Caro JJ , Salas M , Ward A , Getsios D , Mehnert A
Ref : Dementia & Geriatric Cognitive Disorders , 14 :84 , 2002
Abstract : Caro_2002_Dement.Geriatr.Cogn.Disord_14_84
ESTHER : Caro_2002_Dement.Geriatr.Cogn.Disord_14_84
PubMedSearch : Caro_2002_Dement.Geriatr.Cogn.Disord_14_84
PubMedID: 12145455